Home
About
Overview
Sharing Data
ORCID
Help
History (15)
The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST.
Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition Activity.
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
Germline mutations and age at onset of lung adenocarcinoma.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Germline mutations and age at onset of lung adenocarcinoma.
Germline mutations and age at onset of lung adenocarcinoma. Cancer. 2021 08 01; 127(15):2801-2806.
View in:
PubMed
subject areas
Adult
Age of Onset
Aged
Aged, 80 and over
Early Detection of Cancer
Female
Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Lung Neoplasms
Middle Aged
Retrospective Studies
authors with profiles
Ravi Salgia